{"entity":{"type":"insider","cik":"0001451526","url":"/insider/0001451526","json_url":"/insider/0001451526.json","name":"Delphi BioInvestments VIII LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":10,"first":"2009-03-04","last":"2016-03-23","span_basis":"filed_date"},"name_variants":[{"name":"Delphi BioInvestments VIII LP","source":"filing","n_filings":10,"first_seen":"2009-03-04","last_seen":"2016-03-23"}],"transactions":[{"id":3208873,"accession":"0001209191-16-110187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-110187","line_url":"/filing/0001209191-16-110187","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"Senseonics Holdings, Inc.","issuer_ticker":"SENS","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"PAKIANATHAN DEEPIKA; DOUGLASS DAVID L; Delphi Management Partners VIII, L.L.C.; BOCHNOWSKI JAMES J; Delphi BioInvestments VIII LP; ROEDER DOUGLAS A; DELPHI VENTURES VIII LP","owner_display_name":"PAKIANATHAN DEEPIKA","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1228070.0,"shares_display":"1,228,070","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":3499999.5,"total_display":"3,499,999.50","total_whole":"3,500,000","shares_owned_after":11237221.0,"shares_owned_after_display":"11,237,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-23","filed_date":"2016-03-23","scope":"insider","n_lines":2},{"id":6205582,"accession":"0001209191-14-062753","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-062753","line_url":"/filing/0001209191-14-062753","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP; PAKIANATHAN DEEPIKA; ROEDER DOUGLAS A; BOCHNOWSKI JAMES J; Delphi BioInvestments VIII LP; DOUGLASS DAVID L","owner_display_name":"Delphi Management Partners VIII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2403238.0,"shares_owned_after_display":"2,403,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":6717430,"accession":"0000906344-14-000024","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000906344-14-000024","line_url":"/filing/0000906344-14-000024#line-6","is_derivative":false,"issuer_cik":"0001255743","issuer_name":"TriVascular Technologies, Inc.","issuer_ticker":"TRIV","issuer_name_source":null,"issuer_url":"/issuer/0001255743","owner_cik":null,"owner_name":"DOUGLASS DAVID L; Delphi Management Partners VIII, L.L.C.; PAKIANATHAN DEEPIKA; ROEDER DOUGLAS A; DELPHI BIOINVESTMENTS VII LP; Delphi BioInvestments VIII LP; Delphi Management Partners VII, L.L.C.; DELPHI VENTURES VIII LP; BOCHNOWSKI JAMES J; DELPHI VENTURES VII L P","owner_display_name":"DOUGLASS DAVID L","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":833333.0,"shares_display":"833,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":9999996.0,"total_display":"9,999,996.00","total_whole":"9,999,996","shares_owned_after":833333.0,"shares_owned_after_display":"833,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-22","filed_date":"2014-04-24","scope":"insider"},{"id":8925562,"accession":"0001181431-11-050371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-050371","line_url":"/filing/0001181431-11-050371","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VI LP; DELPHI BIOINVESTMENTS VI LP; DELPHI MANAGEMENT PARTNERS VI LLC; Delphi BioInvestments VIII LP; Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP","owner_display_name":"DELPHI VENTURES VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1538461.0,"shares_display":"1,538,461","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":4999998.25,"total_display":"4,999,998.25","total_whole":"4,999,998","shares_owned_after":2410523.0,"shares_owned_after_display":"2,410,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-21","filed_date":"2011-09-23","scope":"insider","n_lines":2},{"id":5921389,"accession":"0001181431-09-048063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-09-048063","line_url":"/filing/0001181431-09-048063","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi BioInvestments VIII LP; Delphi Management Partners VIII, L.L.C.","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":4.6899,"price_display":"4.69","price_state":"stated","total_value":703485.0,"total_display":"703,485.00","total_whole":"703,485","shares_owned_after":886939.0,"shares_owned_after_display":"886,939","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-19","filed_date":"2009-10-20","scope":"insider","n_lines":2},{"id":5921385,"accession":"0001181431-09-048063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-048063","line_url":"/filing/0001181431-09-048063","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi BioInvestments VIII LP; Delphi Management Partners VIII, L.L.C.","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65000.0,"shares_display":"65,000","price_per_share":4.6146,"price_display":"4.61","price_state":"stated","total_value":299949.0,"total_display":"299,949.00","total_whole":"299,949","shares_owned_after":738389.0,"shares_owned_after_display":"738,389","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-16","filed_date":"2009-10-20","scope":"insider","n_lines":2},{"id":5734983,"accession":"0001181431-09-044781","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-09-044781","line_url":"/filing/0001181431-09-044781","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"Delphi BioInvestments VIII LP; DELPHI VENTURES VIII LP; Delphi Management Partners VIII, L.L.C.","owner_display_name":"Delphi BioInvestments VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":44910.0,"total_display":"44,910.00","total_whole":"44,910","shares_owned_after":674018.0,"shares_owned_after_display":"674,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-22","filed_date":"2009-09-22","scope":"insider","n_lines":2},{"id":5734981,"accession":"0001181431-09-044781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-044781","line_url":"/filing/0001181431-09-044781","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"Delphi BioInvestments VIII LP; DELPHI VENTURES VIII LP; Delphi Management Partners VIII, L.L.C.","owner_display_name":"Delphi BioInvestments VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":4.8868,"price_display":"4.89","price_state":"stated","total_value":195472.0,"total_display":"195,472.00","total_whole":"195,472","shares_owned_after":665105.0,"shares_owned_after_display":"665,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-22","scope":"insider","n_lines":2},{"id":6068950,"accession":"0001181431-09-035293","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-09-035293","line_url":"/filing/0001181431-09-035293","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP; Delphi BioInvestments VIII LP","owner_display_name":"Delphi Management Partners VIII, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":59600.0,"total_display":"59,600.00","total_whole":"59,600","shares_owned_after":625492.0,"shares_owned_after_display":"625,492","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-14","filed_date":"2009-07-14","scope":"insider","n_lines":2},{"id":6068947,"accession":"0001181431-09-035293","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-09-035293","line_url":"/filing/0001181431-09-035293","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP; Delphi BioInvestments VIII LP","owner_display_name":"Delphi Management Partners VIII, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":5.9133,"price_display":"5.91","price_state":"stated","total_value":88699.5,"total_display":"88,699.50","total_whole":"88,700","shares_owned_after":615589.0,"shares_owned_after_display":"615,589","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-13","filed_date":"2009-07-14","scope":"insider","n_lines":2},{"id":6068941,"accession":"0001181431-09-035293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-035293","line_url":"/filing/0001181431-09-035293","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"Delphi Management Partners VIII, L.L.C.; DELPHI VENTURES VIII LP; Delphi BioInvestments VIII LP","owner_display_name":"Delphi Management Partners VIII, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31600.0,"shares_display":"31,600","price_per_share":5.98,"price_display":"5.98","price_state":"stated","total_value":188968.0,"total_display":"188,968.00","total_whole":"188,968","shares_owned_after":600734.0,"shares_owned_after_display":"600,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-10","filed_date":"2009-07-14","scope":"insider","n_lines":2},{"id":5920862,"accession":"0001181431-09-033318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-033318","line_url":"/filing/0001181431-09-033318","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi BioInvestments VIII LP; Delphi Management Partners VIII, L.L.C.","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":5.98,"price_display":"5.98","price_state":"stated","total_value":239200.0,"total_display":"239,200.00","total_whole":"239,200","shares_owned_after":569440.0,"shares_owned_after_display":"569,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-06-29","filed_date":"2009-07-01","scope":"insider","n_lines":2},{"id":5878700,"accession":"0001181431-09-014224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-014224","line_url":"/filing/0001181431-09-014224","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi Management Partners VIII, L.L.C.; Delphi BioInvestments VIII LP","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105000.0,"shares_display":"105,000","price_per_share":5.7967,"price_display":"5.80","price_state":"stated","total_value":608653.5,"total_display":"608,653.50","total_whole":"608,654","shares_owned_after":529827.0,"shares_owned_after_display":"529,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-05","filed_date":"2009-03-06","scope":"insider","n_lines":2},{"id":5690547,"accession":"0001181431-09-013780","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-09-013780","line_url":"/filing/0001181431-09-013780","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi Management Partners VIII, L.L.C.; Delphi BioInvestments VIII LP","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65000.0,"shares_display":"65,000","price_per_share":5.9708,"price_display":"5.97","price_state":"stated","total_value":388102.0,"total_display":"388,102.00","total_whole":"388,102","shares_owned_after":425842.0,"shares_owned_after_display":"425,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-04","filed_date":"2009-03-04","scope":"insider","n_lines":2},{"id":5690545,"accession":"0001181431-09-013780","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-09-013780","line_url":"/filing/0001181431-09-013780","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi Management Partners VIII, L.L.C.; Delphi BioInvestments VIII LP","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115000.0,"shares_display":"115,000","price_per_share":5.86,"price_display":"5.86","price_state":"stated","total_value":673900.0,"total_display":"673,900.00","total_whole":"673,900","shares_owned_after":361471.0,"shares_owned_after_display":"361,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-03","filed_date":"2009-03-04","scope":"insider","n_lines":2},{"id":5690543,"accession":"0001181431-09-013780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-013780","line_url":"/filing/0001181431-09-013780","is_derivative":false,"issuer_cik":"0001230355","issuer_name":"TRANS1 INC","issuer_ticker":"TSON","issuer_name_source":null,"issuer_url":"/issuer/0001230355","owner_cik":null,"owner_name":"DELPHI VENTURES VIII LP; Delphi Management Partners VIII, L.L.C.; Delphi BioInvestments VIII LP","owner_display_name":"DELPHI VENTURES VIII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":5.88,"price_display":"5.88","price_state":"stated","total_value":1176000.0,"total_display":"1,176,000.00","total_whole":"1,176,000","shares_owned_after":247583.0,"shares_owned_after_display":"247,583","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001616543","name":"Senseonics Holdings, Inc.","url":"/issuer/0001616543","role":"Ten percent owner","n_filings":1,"first_seen":"2016-03-23","last_seen":"2016-03-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001496671","name":"Calithera Biosciences, Inc.","url":"/issuer/0001496671","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-09","last_seen":"2014-10-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001432732","name":"TriVascular Technologies, Inc.","url":"/issuer/0001432732","role":"Ten percent owner","n_filings":1,"first_seen":"2014-04-24","last_seen":"2014-04-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001230355","name":"TRANS1 INC","url":"/issuer/0001230355","role":"Ten percent owner","n_filings":7,"first_seen":"2009-03-04","last_seen":"2011-09-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001451526","retrieved_at":"2026-08-24T22:15:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}